Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-42.36	27.92	48.44
Graham Fair Price	21.69	2.21	1.82
PEG	10072.73	0.23	< 0.005
Price/Book	9.77	2.54	2.32
Price/Cash Flow	inf	0.00	30.94
Prices/Earnings	-20.17	12.44	15.58
Price/Sales	-9.57	4.83	5.34
Price/FCF	inf	0.00	30.94
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	208.36	0.17	0.06
Operating Margin	119.53	0.17	0.08
ROA	49.38	0.02	0.01
ROE	0.04	0.05	37.51
ROIC	0.01	0.03	172.34
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.12	0.02	437.01
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	13.56	1.77	-86.98
EPS QOQ	70.00	0.55	-99.22
FCF QOQ	2.63	0.00	inf
Revenue QOQ	0.22	0.26	18.04
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	52.68	41.12	-21.93
Days Sales Outstanding (DSO)	73.37	53.43	-27.19
Inventory Turnover	1.71	2.19	28.10
Debt/Capitalization	0.61	0.57	-7.14
Quick Ratio	1.44	1.59	9.95
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.99	2.06	3.77
Cash	1.24	0.95	-23.88
Capex	-0.04	n.A.	n.A.
Free Cash Flow	0.15	n.A.	n.A.
Revenue	0.86	1.09	25.97
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.83	2.17	18.77
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.49	7.83	-49.45
Naive Interpretation	Member

06 - Financial Health · Bad

Rating